Yi-Hsiu Huang

Dr. Eric Y.H. Huang currently serves as Chief of the Department of Urology at Taipei Veterans General Hospital and as an Associate Professor at the School of Medicine, National Yang Ming Chiao Tung University. He is also a Director of the Taiwan Urological Association. Dr. Huang earned his M.D. and completed his Ph.D. in Biomedical Engineering at National Yang-Ming University. He completed his surgical and urological training at Taipei Veterans General Hospital, where he continues to contribute as a senior clinician and educator. In 2010–2011, Dr. Huang was a visiting scholar at the USC Institute of Urology in Los Angeles, where he received advanced training in laparoscopic and robotic surgery. This international experience significantly shaped his clinical expertise and helped advance the application of minimally invasive surgical techniques in Taiwan. Dr. Huang’s academic career includes over a decade of teaching, with appointments at National Yang Ming Chiao Tung University. He is a dedicated peer reviewer for numerous international journals and an active member of several professional societies, including the Endourological Society and the Taiwan Urological Society. With a career that bridges clinical excellence, surgical innovation, and academic leadership, Dr. Huang continues to play an influential role in the development of modern urologic surgery and medical education in Taiwan and beyond.

15th August 2025

Time	Session

13:30 15:00	Industry Symposium 3 【Sonablate】 Advancing Focal Therapy in Localized Prostate Cancer: From Patient Stratification to Post-HIFU Management Introduction and Welcome Po-Hui Chiang Taiwan Speaker Shoji SunaoJapan Speaker Update of Localized Prostate Cancer Therapy Yi-Hsiu HuangTaiwan Moderator Jen-Chieh ChenTaiwan Speaker Who is NOT the patient for Focal Therapy? Kae Jack Tay Singapore Moderator Vincent KhorMalaysia Speaker Oncological and Functional Outcomes of Focal Therapy Kuan-Chou ChenTaiwan Moderator Peter Ka-Fung ChiuHong Kong, China Speaker Minimal Invasive Therapy: Where do We Stand in 2025Endourological, Laparoscopic and robotic surgeries have replaced most open surgeries in Urology. Emergence of new robotic platforms have provided urologists with new opportunities. Both boom-type and module-type robots have been used, and they each have their strengths in practice. Tele-surgeries have provided a new paradigm of long-distance robotic surgeries to facilitate new surgical possibilities and proctorship. State of the art robotic surgeries in retrograde intrarenal surgeries and enbloc resection MDT Discussion: Personalizing Treatment in High Volume CSPCN/ADebate: Should We Only Offer Consolidative Cytoreductive Nephrectomy in Metastatic RCC?N/AFocal Therapy in Asia – Is It Prime Time?The increase in incidence of Prostate cancer has been rapid in Asia in the past 10 years. While Robotic radical prostatectomy and Radiotherapy has been the commonest treatments for localized prostate cancer, significant long-term morbidities are observed after surgery or radiotherapy including incontinence, erectile dysfunction and irradiation injury to the bladder and rectum. In the current era of MRI-guided prostate biopsy, focal diseases can be targeted and diagnosed, and image-guided focal therapy emerged as an alternative treatment. Although Focal therapy has a relatively higher rate of local recurrence, it has the advantages of minimal or no long-term complication after treatment, and it is possible to perform retreatment with focal therapy, prostatectomy or radiotherapy. In properly selected patients, the need for salvage prostatectomy or radiotherapy after focal therapy is less than 20% at 8 years, and patients’ quality of life could be preserved. In well-selected patients, focal therapy is an attractive option. Current focal therapy for prostate cancer available in Asia includes HIFU, Cryotherapy, Targeted Microwave Ablation (TMA), irreversible electroporation (IRE) and TULSA. Beyond Oncologic Control: Real-World Experience in Patient-Centered HIFU for Prostate Disease Shin-Hong ChenTaiwan Moderator L Sivaneswaran LechmiannandanMalaysia Speaker Follow-Up after HIFU Treatment Yu ChenTaiwan Moderator Po-Fan HsiehTaiwan Speaker Panel Discussion Mark EmbertonUnited Kingdom Moderator Shoji SunaoJapan Moderator Jacob See-Tong PangTaiwan Moderator Po-Hui Chiang Taiwan Moderator Closing Jacob See-Tong PangTaiwan Speaker TICC - 1F 101B
13:30 15:00	Free Paper 【Video】 (1) Novel Advances (A): Prostate Alexandr SereginRussia Moderator Naoki TeradaJapan Moderator Yi-Hsiu HuangTaiwan Moderator TWTC - 1F Exhibition Hall